SEARCH FIRM NEWS
This week’s video is presented by Rend Al-Mondhiry on Prop 65 tips – check out the link attached!
https://www.nutraingredients-usa.com/Article/2021/02/23/FTC-action-on-Made-in-USA-claims-signals-heightened-risk-for-industry-attorney-says#
We are all so busy, but who doesn’t have one minute to learn something! Check out our brand new “home video” series “Amin In A Minute” with a welcome message from Ivan Wasserman. We hope you like it!
Interview with George Spatz of Amin Talati Wasserman, LLP.
Leading regulatory and intellectual property law firm Amin Talati Wasserman LLP today announced that prominent medical technology patent attorney Peter Paredes has joined the firm as a partner in Chicago. CHICAGO (PRWEB) JANUARY 21, 2021 Peter Paredes focuses his practice in the fields of biotechnology, nanotechnology, medical devices, genomics, diagnostic systems, drug delivery systems, optical imaging systems, […]
The COVID-19 public health emergency brought about a sudden and unexpected need for personal protective equipment and other medical devices. In response, the Food and Drug Administration (FDA) issued a number of guidance documents that, among other things, waived the premarket notification (510(k)) requirement for the lawful distribution of these devices during the public health […]
Monday, Nov. 16, 2020 • 1:30 p.m. – 3:00 p.m. EST In the past, it’s been difficult to get marketing authorization from the FDA for novel medical device technologies — and even if those authorizations were made, it could take years for a Centers for Medicare and Medicaid Services (CMS) coverage decision. Not anymore. With […]
Leading regulatory and intellectual property law firm Amin Talati Wasserman LLP today announced that prominent litigation attorney George Spatz has joined the firm as a partner and is leading the firm’s litigation practice group. CHICAGO (PRWEB) SEPTEMBER 16, 2020 George Spatz has nearly two decades of experience litigating cases in federal and state court, alternative dispute resolution […]
In its coverage of the leadership shakeup at FDA and the appointment of a new commissioner, NutraIngredients turned to Ivan Wasserman for comment.
see all news >